Variant report

Variant	nsv528686
Chromosome Location	chr4:165814359-165930168
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1624)
CpG islands
(count:2076)
Chromatin interactive
region (count:24)
LncRNA
region (count:21)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1624 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr4:165820081-165820453	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr4:165877669-165878118	GM12878	blood:	n/a	n/a
3	ATF2	chr4:165898293-165899043	GM12878	blood:	n/a	n/a
4	ATF2	chr4:165819988-165820431	H1-hESC	embryonic stem cell:	n/a	n/a
5	BATF	chr4:165857047-165857297	GM12878	blood:	n/a	n/a
6	BATF	chr4:165815851-165816286	GM12878	blood:	n/a	n/a
7	BATF	chr4:165856995-165857356	GM12878	blood:	n/a	n/a
8	BATF	chr4:165815873-165816270	GM12878	blood:	n/a	n/a
9	BCL11A	chr4:165857038-165857347	GM12878	blood:	n/a	n/a
10	BCL11A	chr4:165856980-165857343	GM12878	blood:	n/a	n/a
11	BCLAF1	chr4:165877809-165878342	GM12878	blood:	n/a	n/a
12	BCLAF1	chr4:165898340-165899117	GM12878	blood:	n/a	chr4:165898823-165898832
13	BHLHE40	chr4:165857075-165857535	GM12878	blood:	n/a	n/a
14	BHLHE40	chr4:165877853-165878275	GM12878	blood:	n/a	n/a
15	BHLHE40	chr4:165898610-165899070	GM12878	blood:	n/a	n/a
16	BHLHE40	chr4:165927629-165927864	K562	blood:	n/a	n/a
17	BHLHE40	chr4:165880700-165880797	HepG2	liver:	n/a	n/a
18	BHLHE40	chr4:165877987-165878027	K562	blood:	n/a	n/a
19	BHLHE40	chr4:165815953-165816206	GM12878	blood:	n/a	n/a
20	BRCA1	chr4:165859210-165859241	GM12878	blood:	n/a	n/a
21	BRCA1	chr4:165898635-165898831	GM12878	blood:	n/a	n/a
22	CBX3	chr4:165877855-165878292	K562	blood:	n/a	n/a
23	CEBPB	chr4:165928087-165928406	HepG2	liver:	n/a	n/a
24	CEBPB	chr4:165814884-165815014	A549	lung:	n/a	n/a
25	CEBPB	chr4:165893196-165893391	K562	blood:	n/a	n/a
26	CEBPB	chr4:165826047-165826433	A549	lung:	n/a	chr4:165826085-165826098 chr4:165826399-165826410
27	CEBPB	chr4:165814888-165815064	K562	blood:	n/a	n/a
28	CEBPB	chr4:165924291-165924463	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr4:165846154-165846243	K562	blood:	n/a	n/a
30	CEBPB	chr4:165824559-165824582	H1-hESC	embryonic stem cell:	n/a	n/a
31	CEBPB	chr4:165918720-165918746	H1-hESC	embryonic stem cell:	n/a	n/a
32	CEBPB	chr4:165834769-165834969	K562	blood:	n/a	n/a
33	CEBPB	chr4:165826081-165826493	H1-hESC	embryonic stem cell:	n/a	chr4:165826085-165826098 chr4:165826399-165826410
34	CEBPB	chr4:165834764-165834970	HepG2	liver:	n/a	n/a
35	CEBPB	chr4:165846118-165846395	HepG2	liver:	n/a	chr4:165846274-165846285
36	CEBPB	chr4:165918673-165918803	K562	blood:	n/a	n/a
37	CEBPB	chr4:165814991-165815031	H1-hESC	embryonic stem cell:	n/a	n/a
38	CEBPB	chr4:165826250-165826537	K562	blood:	n/a	chr4:165826399-165826410
39	CEBPB	chr4:165826242-165826531	HepG2	liver:	n/a	chr4:165826399-165826410
40	CEBPB	chr4:165824361-165824554	K562	blood:	n/a	n/a
41	CHD1	chr4:165858664-165859460	GM12878	blood:	n/a	n/a
42	CHD1	chr4:165857436-165858121	GM12878	blood:	n/a	n/a
43	CHD2	chr4:165877860-165878562	GM12878	blood:	n/a	n/a
44	CHD2	chr4:165867270-165867286	GM12878	blood:	n/a	n/a
45	CHD2	chr4:165877922-165878553	H1-hESC	embryonic stem cell:	n/a	n/a
46	CHD2	chr4:165816236-165816280	GM12878	blood:	n/a	n/a
47	CHD2	chr4:165857085-165858018	GM12878	blood:	n/a	n/a
48	CHD2	chr4:165858814-165859380	GM12878	blood:	n/a	n/a
49	CHD2	chr4:165898446-165899204	GM12878	blood:	n/a	n/a
50	CREB1	chr4:165877817-165878316	A549	lung:	n/a	n/a

(count:2076 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:165878055-165878105	NB4	blood:	n/a
2	chr4:165876955-165877005	PFSK-1	brain:	n/a
3	chr4:165878055-165878105	NB4	blood:	n/a
4	chr4:165876955-165877005	PFSK-1	brain:	n/a
5	chr4:165900224-165900274	GM12891	blood:	n/a
6	chr4:165898926-165898976	GM12892	blood:	n/a
7	chr4:165878219-165878269	SKMC	muscle:	n/a
8	chr4:165875543-165875593	NT2-D1	testis:	n/a
9	chr4:165898666-165898716	GM19239	blood:	n/a
10	chr4:165878317-165878367	Caco-2	colon:	n/a
11	chr4:165900285-165900335	SK-N-SH	brain:	n/a
12	chr4:165854181-165854231	SK-N-MC	brain:	n/a
13	chr4:165898707-165898757	H1-hESC	embryonic stem cell:	embryo
14	chr4:165898825-165898875	CMK	blood:	n/a
15	chr4:165854181-165854231	HEK293	kidney:	embryo
16	chr4:165875543-165875593	ProgFib	skin:	n/a
17	chr4:165878037-165878087	HEK293	kidney:	embryo
18	chr4:165877875-165877925	PrEC	prostate:	n/a
19	chr4:165851859-165851909	GM12878	blood:	n/a
20	chr4:165876955-165877005	HL-60	blood:	n/a
21	chr4:165878136-165878186	GM19239	blood:	n/a
22	chr4:165878742-165878792	HCF	heart:	n/a
23	chr4:165878055-165878105	A549	lung:	n/a
24	chr4:165898825-165898875	ovcar-3	ovarian:	n/a
25	chr4:165878055-165878105	GM12878	blood:	n/a
26	chr4:165881424-165881474	HPAEpiC	pulmonary alveolar:	n/a
27	chr4:165898825-165898875	HNPCEpiC	eye:	n/a
28	chr4:165881424-165881474	HRCEpiC	kidney:	n/a
29	chr4:165851077-165851127	NT2-D1	testis:	n/a
30	chr4:165898848-165898898	HCF	heart:	n/a
31	chr4:165854246-165854296	GM12892	blood:	n/a
32	chr4:165898666-165898716	HPAEpiC	pulmonary alveolar:	n/a
33	chr4:165898912-165898962	IMR90	lung:	fetal
34	chr4:165898912-165898962	HUVEC	blood vessel:	n/a
35	chr4:165898835-165898885	ovcar-3	ovarian:	n/a
36	chr4:165898967-165899017	HCT-116	colon:	n/a
37	chr4:165850972-165851022	IMR90	lung:	fetal
38	chr4:165878091-165878141	IMR90	lung:	fetal
39	chr4:165854246-165854296	Hepatocyte	liver:	n/a
40	chr4:165898926-165898976	ProgFib	skin:	n/a
41	chr4:165881424-165881474	PANC-1	pancreas:	n/a
42	chr4:165878742-165878792	NHDF-neo	bronchial:	n/a
43	chr4:165878085-165878135	H1-hESC	embryonic stem cell:	embryo
44	chr4:165876955-165877005	HRPEpiC	eye:	n/a
45	chr4:165878317-165878367	PrEC	prostate:	n/a
46	chr4:165850972-165851022	H1-hESC	embryonic stem cell:	embryo
47	chr4:165898967-165899017	Hepatocyte	liver:	n/a
48	chr4:165898926-165898976	HL-60	blood:	n/a
49	chr4:165898666-165898716	HRCEpiC	kidney:	n/a
50	chr4:165858544-165858594	Hela-S3	cervix:	n/a

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:165923507..165926386-chr4:165928187..165930464,2	K562	blood:
2	chr4:165830577..165832077-chr7:25164613..25166543,2	MCF-7	breast:
3	chr4:165701014..165701543-chr4:165856051..165856573,2	MCF-7	breast:
4	chr4:165833603..165835632-chr4:165838442..165840941,2	MCF-7	breast:
5	chr4:165868972..165872041-chr4:165876298..165879460,3	MCF-7	breast:
6	chr4:165877284..165881205-chr4:165885674..165889440,5	MCF-7	breast:
7	chr4:165896605..165899172-chr4:165907116..165908745,2	MCF-7	breast:
8	chr4:165876835..165879626-chr4:165882281..165885476,4	MCF-7	breast:
9	chr4:165896605..165899172-chr4:165907116..165908745,2	MCF-7	breast:
10	chr4:165876074..165878048-chr4:165892405..165894471,2	MCF-7	breast:
11	chr4:165877542..165879531-chr4:165880684..165882237,2	MCF-7	breast:
12	chr4:165874581..165877460-chr4:165878651..165880772,2	K562	blood:
13	chr4:165689047..165689634-chr4:165918458..165919146,2	MCF-7	breast:
14	chr4:165833603..165835632-chr4:165838442..165840941,2	MCF-7	breast:
15	chr1:11966992..11968590-chr4:165867023..165868624,2	K562	blood:
16	chr4:165868972..165872041-chr4:165876298..165879460,3	MCF-7	breast:
17	chr4:165876074..165878048-chr4:165892405..165894471,2	MCF-7	breast:
18	chr4:165699281..165700032-chr4:165856272..165857241,2	MCF-7	breast:
19	chr4:165868495..165870203-chr4:165872665..165874987,2	MCF-7	breast:
20	chr4:165856166..165858715-chr4:165877906..165879898,2	MCF-7	breast:
21	chr4:165818735..165821525-chr4:166031427..166033920,2	K562	blood:
22	chr4:165866322..165867965-chr4:165877072..165879577,2	MCF-7	breast:
23	chr4:165874581..165877460-chr4:165878651..165880772,2	K562	blood:
24	chr4:165918473..165921448-chr4:165932774..165935050,2	K562	blood:

(count:21 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TRIM61-4	chr4:165850646-165851103	NONHSAT099089
2	lnc-C4orf39-5	chr4:165911021-165911093	l_2770_chr4:165894766-165911093_prostate
3	lnc-C4orf39-1	chr4:165817960-165818137	ENSG00000248329
4	lnc-C4orf39-1	chr4:165816368-165818669	NONHSAT099084
5	lnc-TMEM192-4	chr4:165889739-165891154	NONHSAT099094
6	lnc-C4orf39-1	chr4:165819878-165820117	ENSG00000248329
7	lnc-C4orf39-1	chr4:165817616-165818137	ENSG00000248329
8	lnc-TRIM61-5	chr4:165841770-165842215	NONHSAT099088
9	lnc-C4orf39-1	chr4:165816568-165818676	NONHSAT099080
10	lnc-C4orf39-3	chr4:165899902-165899980	NONHSAT099093
11	lnc-C4orf39-6	chr4:165836717-165838135	NONHSAT099087
12	lnc-TRIM61-1	chr4:165928238-165928367	XLOC_004145
13	lnc-C4orf39-3	chr4:165869231-165869699	NONHSAT099093
14	lnc-C4orf39-1	chr4:165819878-165820117	ENSG00000248329
15	lnc-TRIM61-1	chr4:165928495-165929111	XLOC_004145
16	lnc-C4orf39-4	chr4:165908417-165908939	NONHSAT099095
17	lnc-C4orf39-3	chr4:165882287-165882345	NONHSAT099093
18	lnc-TRIM61-2	chr4:165856103-165856321	NONHSAT099091
19	lnc-C4orf39-3	chr4:165883229-165883240	NONHSAT099093
20	lnc-C4orf39-1	chr4:165816568-165818675	ENSG00000248329
21	lnc-C4orf39-5	chr4:165894767-165895013	l_2770_chr4:165894766-165911093_prostate

No data

Variant related genes	Relation type
ENSG00000250712	TF binding region
ENSG00000236941	TF binding region
FAM218A	TF binding region
TRIM61	TF binding region
ENSG00000270960	TF binding region
ENSG00000248229	TF binding region
ENSG00000248645	TF binding region
ENSG00000250887	TF binding region
NACA3P	TF binding region
FAM218BP	TF binding region
ENSG00000248329	TF binding region
ENSG00000244146	TF binding region
TRIM60P14	TF binding region
ENSG00000248632	TF binding region
ENSG00000250712	CpG island
ENSG00000236941	CpG island
FAM218A	CpG island
TRIM61	CpG island
ENSG00000270960	CpG island
ENSG00000248229	CpG island
ENSG00000248645	CpG island
ENSG00000250887	CpG island
NACA3P	CpG island
FAM218BP	CpG island
ENSG00000248329	CpG island
ENSG00000244146	CpG island
TRIM60P14	CpG island
ENSG00000248632	CpG island
ENSG00000236941	chromatin interactions
ENSG00000172115	chromatin interactions
ENSG00000240674	chromatin interactions
ENSG00000250486	chromatin interactions
ENSG00000248229	chromatin interactions
ENSG00000250887	chromatin interactions
ENSG00000183439	chromatin interactions
ENSG00000199347	chromatin interactions
RNF149	miRNA target sites
DNAJB4	miRNA target sites
TRAIP	miRNA target sites
TMEM63B	miRNA target sites
SAPS2	miRNA target sites

Extended variants
information (count: 3909 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:3909 , 50 per page) page: 1 2 3 4 5 6 7 ... 79

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7691785	chr4:165814359-165814360	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs76833295	chr4:165814459-165814460	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs573155213	chr4:165814499-165814500	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs540751291	chr4:165814540-165814541	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs562024156	chr4:165814583-165814584	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs568590644	chr4:165814645-165814646	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs529369084	chr4:165814669-165814670	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs145217302	chr4:165814676-165814677	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs190564691	chr4:165814679-165814680	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs112410975	chr4:165814696-165814697	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs551777111	chr4:165814755-165814756	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs13152225	chr4:165814775-165814776	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs534309142	chr4:165814777-165814778	Weak transcription Strong transcription Genic enhancers Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs111647000	chr4:165814806-165814807	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs374347566	chr4:165814844-165814845	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs367699954	chr4:165814847-165814848	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs147654249	chr4:165814895-165814896	Weak transcription Strong transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs370617562	chr4:165814921-165814922	Weak transcription Strong transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs558745189	chr4:165814922-165814923	Weak transcription Strong transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs556749860	chr4:165814987-165814988	Weak transcription Strong transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs13133553	chr4:165815025-165815026	Weak transcription Strong transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs539397744	chr4:165815056-165815057	Weak transcription Strong transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs193243075	chr4:165815064-165815065	Weak transcription Strong transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs184546007	chr4:165815114-165815115	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs540282323	chr4:165815115-165815116	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs369944019	chr4:165815116-165815117	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs562082827	chr4:165815155-165815156	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs142225434	chr4:165815200-165815201	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565261069	chr4:165815201-165815202	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs188949442	chr4:165815203-165815204	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs532417044	chr4:165815281-165815282	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs145781587	chr4:165815349-165815350	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs552077819	chr4:165815354-165815355	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs560639400	chr4:165815435-165815436	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs527959423	chr4:165815455-165815456	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs538153323	chr4:165815456-165815457	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs546282943	chr4:165815484-165815485	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs34056903	chr4:165815488-165815489	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs397723091	chr4:165815496-165815497	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs369110950	chr4:165815562-165815563	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs574887779	chr4:165815565-165815566	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs111465583	chr4:165815569-165815570	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs13107103	chr4:165815573-165815574	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs13134820	chr4:165815575-165815576	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs56931216	chr4:165815581-165815582	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs13134822	chr4:165815583-165815584	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs138364412	chr4:165815584-165815585	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs368419670	chr4:165815587-165815588	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs13107708	chr4:165815589-165815590	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs13107116	chr4:165815590-165815591	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Glioblastoma multiforme	22286061	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	16774939	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Myelofibrosis	22110671	CNVD
intellectual deficit	22127048	CNVD
abnormal development	18461090	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:946 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:165800800-165822400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr4:165805800-165814400	Strong transcription	iPS-18 Cell Line	embryonic stem cell
3	chr4:165806400-165815200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr4:165806400-165818600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
5	chr4:165809800-165816000	Weak transcription	H9 Cell Line	embryonic stem cell
6	chr4:165809800-165819400	Strong transcription	HUES48 Cell Line	embryonic stem cell
7	chr4:165811600-165816000	Weak transcription	HUES64 Cell Line	embryonic stem cell
8	chr4:165812200-165820200	Strong transcription	iPS-20b Cell Line	embryonic stem cell
9	chr4:165813400-165815600	Weak transcription	H1 Cell Line	embryonic stem cell
10	chr4:165813400-165825200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
11	chr4:165813600-165815600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
12	chr4:165813600-165815800	Enhancers	GM12878-XiMat	blood
13	chr4:165813600-165826200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
14	chr4:165813800-165816000	Weak transcription	HUES6 Cell Line	embryonic stem cell
15	chr4:165814400-165814800	Genic enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr4:165814800-165815400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
17	chr4:165815200-165816200	Strong transcription	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr4:165815400-165819200	Strong transcription	iPS-18 Cell Line	embryonic stem cell
19	chr4:165815600-165819200	Strong transcription	ES-UCSF4 Cell Line	embryonic stem cell
20	chr4:165815600-165820400	Strong transcription	H1 Cell Line	embryonic stem cell
21	chr4:165815800-165816400	Flanking Active TSS	GM12878-XiMat	blood
22	chr4:165816000-165819000	Strong transcription	HUES6 Cell Line	embryonic stem cell
23	chr4:165816000-165819200	Strong transcription	H9 Cell Line	embryonic stem cell
24	chr4:165816000-165820200	Strong transcription	HUES64 Cell Line	embryonic stem cell
25	chr4:165816200-165823200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr4:165818600-165819000	Strong transcription	ES-I3 Cell Line	embryonic stem cell
27	chr4:165819000-165825400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
28	chr4:165819000-165825800	Weak transcription	HUES6 Cell Line	embryonic stem cell
29	chr4:165819200-165823200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
30	chr4:165819200-165823600	Weak transcription	H9 Cell Line	embryonic stem cell
31	chr4:165819200-165825600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
32	chr4:165819400-165825800	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr4:165820200-165826600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
34	chr4:165820200-165827600	Weak transcription	HUES64 Cell Line	embryonic stem cell
35	chr4:165820400-165825200	Weak transcription	H1 Cell Line	embryonic stem cell
36	chr4:165822400-165822600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr4:165822600-165823200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr4:165823200-165823400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
39	chr4:165823200-165824000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr4:165823200-165824000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr4:165823400-165823800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
42	chr4:165824000-165825200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr4:165824000-165825200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr4:165824200-165824400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr4:165825200-165825800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr4:165825200-165825800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr4:165825200-165826400	Enhancers	H1 Cell Line	embryonic stem cell
48	chr4:165825200-165826800	Enhancers	Placenta	Placenta
49	chr4:165825400-165825600	Enhancers	ES-I3 Cell Line	embryonic stem cell
50	chr4:165825600-165826000	Weak transcription	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links